Xiaowei Ge

749 total citations
30 papers, 606 citations indexed

About

Xiaowei Ge is a scholar working on Public Health, Environmental and Occupational Health, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, Xiaowei Ge has authored 30 papers receiving a total of 606 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Public Health, Environmental and Occupational Health, 9 papers in Endocrinology, Diabetes and Metabolism and 7 papers in Molecular Biology. Recurrent topics in Xiaowei Ge's work include Pharmaceutical Quality and Counterfeiting (22 papers), Hormonal and reproductive studies (8 papers) and Identification and Quantification in Food (5 papers). Xiaowei Ge is often cited by papers focused on Pharmaceutical Quality and Counterfeiting (22 papers), Hormonal and reproductive studies (8 papers) and Identification and Quantification in Food (5 papers). Xiaowei Ge collaborates with scholars based in Singapore, China and France. Xiaowei Ge's co-authors include Min‐Yong Low, Chee‐Leong Kee, Hwee‐Ling Koh, Lin Li, Bosco Chen Bloodworth, Véronique Gilard, Myriam Malet‐Martino, Peng Zou, Ruth Lee and Philippe Girard and has published in prestigious journals such as Journal of Chromatography A, Analytical and Bioanalytical Chemistry and Rapid Communications in Mass Spectrometry.

In The Last Decade

Xiaowei Ge

29 papers receiving 580 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaowei Ge Singapore 15 483 183 131 101 99 30 606
Chee‐Leong Kee Singapore 10 306 0.6× 119 0.7× 84 0.6× 63 0.6× 57 0.6× 19 398
Min‐Yong Low Singapore 19 862 1.8× 290 1.6× 226 1.7× 184 1.8× 218 2.2× 40 1.1k
Soo-Yeul Cho South Korea 18 268 0.6× 297 1.6× 49 0.4× 173 1.7× 260 2.6× 52 930
Kyoung Moon Han South Korea 13 176 0.4× 93 0.5× 45 0.3× 77 0.8× 40 0.4× 20 456
Bosco Chen Bloodworth Singapore 12 172 0.4× 156 0.9× 45 0.3× 97 1.0× 33 0.3× 21 455
Cheryl L. Flurer United States 17 242 0.5× 161 0.9× 47 0.4× 96 1.0× 81 0.8× 22 754
Albert Y W Chan Hong Kong 17 105 0.2× 220 1.2× 16 0.1× 43 0.4× 74 0.7× 29 616
Deborah Custers Belgium 13 112 0.2× 134 0.7× 17 0.1× 144 1.4× 14 0.1× 16 423
Huda Hassan Saudi Arabia 9 124 0.3× 93 0.5× 9 0.1× 150 1.5× 29 0.3× 15 525
Livia Manna Italy 13 94 0.2× 61 0.3× 17 0.1× 57 0.6× 20 0.2× 20 408

Countries citing papers authored by Xiaowei Ge

Since Specialization
Citations

This map shows the geographic impact of Xiaowei Ge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaowei Ge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaowei Ge more than expected).

Fields of papers citing papers by Xiaowei Ge

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaowei Ge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaowei Ge. The network helps show where Xiaowei Ge may publish in the future.

Co-authorship network of co-authors of Xiaowei Ge

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaowei Ge. A scholar is included among the top collaborators of Xiaowei Ge based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaowei Ge. Xiaowei Ge is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kee, Chee‐Leong, Xiaowei Ge, Min‐Yong Low, & Laura A. Ciolino. (2025). Analysis of Amine Drugs Dissolved in Methanol by High‐Resolution Accurate Mass Gas Chromatography Mass Spectrometry, GC‐Orbitrap. Journal of Mass Spectrometry. 60(5). e5127–e5127.
2.
Kee, Chee‐Leong, Xiaowei Ge, Min‐Yong Low, Véronique Gilard, & Myriam Malet‐Martino. (2023). Analytical methods for the detection and characterization of unapproved phosphodiesterase type 5 inhibitors (PDE-5i) used in adulteration of dietary supplements- a review. Food Additives & Contaminants Part A. 40(12). 1495–1530. 6 indexed citations
3.
Kee, Chee‐Leong, Min‐Yong Low, & Xiaowei Ge. (2021). Isolation and characterization of N-phenyl propoxyphenyl carbodenafil from an illegal coffee powder product. Journal of Pharmaceutical and Biomedical Analysis. 209. 114481–114481. 4 indexed citations
4.
Kee, Chee‐Leong, et al.. (2020). Isolation and characterization of N-hydroxyethyl dithio-desethyl carbodenafil from a health supplement. Journal of Pharmaceutical and Biomedical Analysis. 189. 113431–113431. 5 indexed citations
5.
Kee, Chee‐Leong, Min‐Yong Low, & Xiaowei Ge. (2017). Isolation and characterization of a novel dithio-carbodenafil analogue from a health supplement. Journal of Pharmaceutical and Biomedical Analysis. 137. 132–138. 8 indexed citations
6.
Kee, Chee‐Leong, Xiaowei Ge, Véronique Gilard, Myriam Malet‐Martino, & Min‐Yong Low. (2017). A review of synthetic phosphodiesterase type 5 inhibitors (PDE-5i) found as adulterants in dietary supplements. Journal of Pharmaceutical and Biomedical Analysis. 147. 250–277. 65 indexed citations
7.
Kee, Chee‐Leong, et al.. (2015). Analysis of 32 toxic natural substances in herbal products by liquid chromatography quadrupole linear ion trap mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis. 115. 169–173. 12 indexed citations
8.
Kee, Chee‐Leong, et al.. (2015). Isolation and characterization of a tadalafil analogue, N -cyclopentyl nortadalafil in health supplement. Journal of Pharmaceutical and Biomedical Analysis. 118. 235–241. 10 indexed citations
9.
Kee, Chee‐Leong, et al.. (2014). Structural elucidation of propoxyphenyl isobutyl aildenafil, adulterant in a health supplement using high-resolution Orbitrap mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis. 98. 153–159. 9 indexed citations
10.
Kee, Chee‐Leong, Xiaowei Ge, Min‐Yong Low, & Hwee‐Ling Koh. (2013). Structural elucidation of a new sildenafil analogue using high‐resolution Orbitrap mass spectrometry. Rapid Communications in Mass Spectrometry. 27(12). 1380–1384. 15 indexed citations
11.
Lai, Chian Sing, et al.. (2012). Partial conversion of methanol to formaldehyde in the gas chromatography injection port and reactivity with amines. Journal of Chromatography A. 1257. 158–170. 6 indexed citations
12.
Li, Lin, Min‐Yong Low, Xiaowei Ge, Bosco Chen Bloodworth, & Hwee‐Ling Koh. (2012). Isolation and structural elucidation of a new sildenafil analogue from a functional coffee. Analytical and Bioanalytical Chemistry. 405(13). 4443–4450. 14 indexed citations
13.
Kee, Chee‐Leong, Xiaowei Ge, Hwee‐Ling Koh, & Min‐Yong Low. (2012). Isolation and characterization of propoxyphenyl linked sildenafil and thiosildenafil analogues in health supplements. Journal of Pharmaceutical and Biomedical Analysis. 70. 265–272. 20 indexed citations
14.
Low, Min‐Yong, Lin Li, Xiaowei Ge, Chee‐Leong Kee, & Hwee‐Ling Koh. (2011). Isolation and structural elucidation of flibanserin as an adulterant in a health supplement used for female sexual performance enhancement. Journal of Pharmaceutical and Biomedical Analysis. 57. 104–108. 16 indexed citations
15.
Ge, Xiaowei, Lin Li, Hwee‐Ling Koh, & Min‐Yong Low. (2011). Identification of a new sildenafil analogue in a health supplement. Journal of Pharmaceutical and Biomedical Analysis. 56(3). 491–496. 33 indexed citations
16.
Girard, Philippe, et al.. (2010). Isolation and structure elucidation of an interaction product of aminotadalafil found in an illegal health food product. Journal of Pharmaceutical and Biomedical Analysis. 53(1). 24–28. 24 indexed citations
17.
Li, Lin, Min‐Yong Low, Xiaowei Ge, Bosco Chen Bloodworth, & Hwee‐Ling Koh. (2009). Isolation and structural elucidation of dapoxetine as an adulterant in a health supplement used for sexual performance enhancement. Journal of Pharmaceutical and Biomedical Analysis. 50(5). 724–728. 18 indexed citations
18.
Low, Min‐Yong, et al.. (2009). Safety and Quality Assessment of 175 Illegal Sexual Enhancement Products Seized in Red-Light Districts in Singapore. Drug Safety. 32(12). 1141–1146. 55 indexed citations
19.
Zou, Peng, Peiling Hou, Xiaowei Ge, et al.. (2008). Identification of benzamidenafil, a new class of phosphodiesterase-5 inhibitor, as an adulterant in a dietary supplement. Journal of Pharmaceutical and Biomedical Analysis. 47(2). 255–259. 32 indexed citations
20.
Ge, Xiaowei, Min‐Yong Low, Peng Zou, et al.. (2008). Structural elucidation of a PDE-5 inhibitor detected as an adulterant in a health supplement. Journal of Pharmaceutical and Biomedical Analysis. 48(4). 1070–1075. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026